Track the Coeptis Therapeutics Holdings, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 13 February 2026 (Levée d'options). Among the most active insiders: Salkind Gene. Every trade is openly available.
18
Insider Decl.
n/a
Thresholds
€57,476
8 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Coeptis Therapeutics Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
52Σ signal
Buys €57,476n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,942 of 29,063 companies
36.9
score / 100
Value
23
Quality
51
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn87%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
28,638 shares@ US$0.9176.7% of flowCommon StockSEC:0001683168-23-006169:0
Canonical exit: 23 Nov 2023 (T+90)
18 of 18 declarations
Acerca de Coeptis Therapeutics Holdings, Inc.
Coeptis Therapeutics Holdings, Inc. es una empresa enfocada en el desarrollo de terapias innovadoras para el tratamiento del cáncer. Cotiza en NASDAQ bajo el ticker COEP.